![]() ![]() Results: Of a total of 2 414 patients enrolled in the study, 1 633 (67.6%) received clopidogrel or aspirin and 781 (32.4%) received DAPT. Cox proportional-hazards models were utilized to investigate the association of treatment strategies and prognosis. The outcomes were stroke recurrence and all-cause mortality at 3 months and at 1 year, respectively. Demographics, medical history, NIHSS score, imaging and laboratory data were collected. In this prospective nationwide cohort, moderate ischemic stroke patients with NIHSS 4–10 and without intravenous thrombolysis or endovascular treatment were included and categorized into mono- or dual-antiplatelet groups. ![]() Methods: Data were derived from the Third China National Stroke Registry (CNSR-Ш). dual-antiplatelet (DAPT) treatment strategies against subsequent stroke for these patients in a nationwide cohort. We aimed to explore the effectiveness of mono- vs. Introduction: Moderate stroke patients with National Institutes of Health Stroke Scale (NIHSS) score of 4–10 and without intravenous thrombolysis or endovascular treatment are basically excluded from current secondary prevention trials. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |